ZeroHarm Sciences raises ₹65 Cr to revolutionize plant-based health supplements globally
ZeroHarm Sciences raises ₹65 Cr to revolutionize plant-based health supplements globally
ZeroHarm Sciences raises ₹65 Cr to revolutionize plant-based health supplements globally
Hyderabad-based nutrition startup ZeroHarm Sciences has secured ₹65 Cr ($7.2 Mn) in its latest funding round. The company, founded in 2020 by Sachin and Shweta Darbarwar, specialises in 100% plant-based health supplements using proprietary nano-formulation technology. Investors include Kotak Alternate Asset Managers and Alkemi Growth Capital, who led the round with contributions of ₹40 Cr and ₹25 Cr respectively.
ZeroHarm Sciences has grown steadily since its launch, expanding its workforce from five founders in 2020 to around 50 employees by 2026. The startup now offers over 60 products across multiple categories, selling through its own website, ecommerce platforms, and quick-commerce channels. To date, it claims to have served more than 3 lakh customers.
The fresh funds will support multiple initiatives. A significant portion will go toward expanding brand presence in India and entering overseas markets, including the US, UK, and the Middle East. The company also plans to develop a 'Trust over Promise' platform, designed to showcase supplement efficacy through measurable health outcomes.
Additionally, ZeroHarm Sciences will scale up its research and manufacturing capabilities. The startup controls its entire production chain, from sourcing medicinal plants to in-house formulation R&D and GMP-certified manufacturing. This vertical integration allows it to maintain strict quality standards across its product range.
With the new investment, ZeroHarm Sciences aims to strengthen its position in the plant-based supplements market. The funds will accelerate global expansion, enhance research, and improve transparency around product effectiveness. The company's focus remains on delivering science-backed, plant-derived health solutions.